Paperpal Prime Logo

Journal of Cardiovascular Development and Disease : Impact Factor & More

eISSN: 2308-3425pISSN: 2308-3425
JournalOpen Access

Key Metrics

CiteScore
3.6
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q4Pharmacology (medical)
SNIP
1.22
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Cardiovascular Development and Disease

Journal of Cardiovascular Development and Disease Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Monthly
Article Processing ChargesCHF 2000
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Journal of Cardiovascular Development and Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Cardiovascular Development and Disease

The Efficacy and Safety of Cardiopulmonary Exercise Testing in Advanced Heart Failure Receiving Intravenous Inotropes
  • 28 Jul 2026
  • Journal of Cardiovascular Development and Disease
From Valve Anatomy to Molecular Trajectories: Integrating Proteomics into Precision Care for Bicuspid Aortic Valve Disease
  • 22 Jul 2026
  • Journal of Cardiovascular Development and Disease
Arrythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management
  • 22 Jul 2026
  • Journal of Cardiovascular Development and Disease
An Artificial Intelligence Model for ECG-Based Prediction of Heart Failure with Preserved Ejection Fraction Diagnosis
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease
The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease
Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease
The Efficacy and Safety of Cardiopulmonary Exercise Testing in Advanced Heart Failure Receiving Intravenous Inotropes
  • 28 Jul 2026
  • Journal of Cardiovascular Development and Disease
From Valve Anatomy to Molecular Trajectories: Integrating Proteomics into Precision Care for Bicuspid Aortic Valve Disease
  • 22 Jul 2026
  • Journal of Cardiovascular Development and Disease
Arrythmias in Autoimmune Diseases: Immune-Mediated Mechanisms and Management
  • 22 Jul 2026
  • Journal of Cardiovascular Development and Disease
An Artificial Intelligence Model for ECG-Based Prediction of Heart Failure with Preserved Ejection Fraction Diagnosis
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease
The Mitigating Effect of Remifentanil Against Sevoflurane-Induced Cardiotoxicity in Human Cardiomyocytes via TRPA1 Channels
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease
Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy
  • 21 Jul 2026
  • Journal of Cardiovascular Development and Disease

FAQs on Journal of Cardiovascular Development and Disease